Articles

Fed won’t cut interest rates right away, Harker says

The president of the Philadelphia Federal Reserve said the central bank doesn't plan to cut interest rates soon because the job on reducing inflation is "not done."

The year that wasn’t: 10 Wall Street forecasts for 2023 that didn’t pan out

Wall Street had a lot of expectations heading into 2023. Looking back 12 months later, it's clear that most of them didn't pan out.

Seven tech stocks that can broaden your exposure beyond the “Magnificent Seven”

During the bull market of 2023, the "Magnificent Seven" stocks have dominated financial media coverage, and rightly so, but investors might want to gain exposure to other important "quality" tech-related names.

A smaller Christmas feast? 66% of people on weight-loss drugs plan to eat healthy during the holidays.

A new survey points to how people on GLP-1 medications, such as Ozempic and Saxenda, are changing their approach to holiday dining.

Nikola’s stock up on deal for hydrogen-fuel infrastructure

Nikola Corp.'s stock was up by 4.7% on Wednesday after the company named FirstElement Fuel Inc. as an authorized Nikola fueling-station partner for hydrogen-powered trucks.

This company never serviced student loans in repayment. Now it’s handling 9 million accounts in an ‘unprecedented’ time.

Post Content

As Colorado court bars Trump from ballot, poll finds 62% of GOP voters would want him as nominee even with more legal woes

In the wake of the news that Colorado's Supreme Court has barred Donald Trump from the state’s presidential primary ballot under the U.S. Constitution’s insurrection clause, a new poll shows how Republican voters are sticking with the former president through his legal problems.

Buy FedEx’s stock on the big dip, analyst says

FedEx's stock has fallen so much on the back of the package delivery giant's earnings miss, that it has created an attractive buying opportunity for investors, one Wall Street analyst said.

Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk? 

The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.

Not sure what to do with your 401(k)? Let these smart people help you.

Valuable lessons from Warren Buffett, Charlie Munger and Morgan Housel can help you invest wisely in retirement.

Why $100,000 can’t support a middle-class family anymore, according to a viral video

There's a gulf between homeowners who bought before the pandemic and those who bought after.

Sticky inflation in a key part of the U.S. economy is the biggest barrier to Fed rate cuts

The Federal Reserve is winning the battle against high inflation, but the fight is not over yet, a parade of senior bank officials told Wall Street this week.
1 886 887 888 889 890 1,563